| Manipal Group, a major player in higher education and healthcare sector, has entered biotech and clinical research space by promoting a company - Manipal Acunova in Bangalore. (visit : www.acunovalife.com) |
| |
| "Manipal Acunova is committed to bringing the intellectual ACUmen of India's leading Health Sciences University to inNOVAtion in drug discovery. Our doctors and biologists bring innovation to drug discovery. Eminent Principal Investigators at our teaching hospital network bring speed to drug approval for clients worldwide." says Mr. D A Prasanna, Vice Chairman & Managing Director of Manipal Acunova |
| |
| Manipal's teaching hospital network treats over 1.2 million patients a year. This gives us strength and advantage to study diseases and genetic profile of various individuals, which are key factors for speedy clinical trials. |
| |
| Mr. D A Prasanna added, "the Manipal group has invited professionals and strategic investors to hold more than 50 % stake in the venture. We will be looking at crossing Rs.100 crore turnover and go for an IPO in the next 5 years." |
| |
| There is a change of attitude towards the East from Western countries for discovery research. Indians and other Asians are working on cutting edge technology in most of the US based biotech companies and research organizations. Some of the US based companies are looking at outsourcing drug discovery research to Indian companies. Manipal Acunova will conduct custom research in drug discovery for bio pharma companies. |
| |
| Initially the company will focus on stem cell research and drug development for cancer and diabetes. |
| |
| Manipal Acunova is Committed to Ethical practice in Healthcare and Clinical Research. |
